Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer.

Journal: BMC cancer
Published Date: Feb 8, 2023

Abstract

BACKGROUND: Few highly accurate tests can diagnose central lymph node metastasis (CLNM) of papillary thyroid cancer (PTC). Genetic sequencing of tumor tissue has allowed the targeting of certain genetic variants for personalized cancer therapy development.

Authors

  • Zhongzhi Wang
    Department of General Surgery, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
  • Limeng Qu
    Department of General Surgery, The Second Xiangya Hospital of Central South University, No. 139, Renmin Central Road, Changsha, 410011, P.R. China.
  • Qitong Chen
    Department of General Surgery, The Second Xiangya Hospital of Central South University, No. 139, Renmin Central Road, Changsha, 410011, P.R. China.
  • Yong Zhou
    National Institutes for Food and Drug Control, Beijing, 100050, China.
  • Hongtao Duan
    Key Laboratory of Watershed Geographic Sciences, Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences, Nanjing 210008, China.
  • Baifeng Li
    Department of General Surgery, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
  • Yao Weng
    Department of Metabolic Endocrinology, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
  • Juan Su
    Department of Dermatology, Xiangya Hospital Central South University, Changsha, China.
  • Wenjun Yi
    Department of General Surgery, The Second Xiangya Hospital of Central South University, No. 139, Renmin Central Road, Changsha, 410011, P.R. China. yiwenjun@csu.edu.cn.

Keywords

External Resources

Popular Topics
Recent Journals